Zydus Lifesciences informs about press release

26 Nov 2025 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated November 26, 2025, titled ‘Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

885.40 9.30 (1.06%)
22-Jan-2026 13:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.55
Dr. Reddys Lab 1221.50
Cipla 1374.00
Zydus Lifesciences 885.40
Lupin 2169.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×